Praxis Precision Medicines, Inc. (PRAX)
334.58
-3.99
(-1.18%)
USD |
NASDAQ |
Sep 11, 16:00
333.00
-1.58
(-0.47%)
After-Hours: 20:00
Praxis Precision Medicines Enterprise Value : 8.583B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 8.583B |
| September 10, 2026 | 8.694B |
| September 09, 2026 | 8.882B |
| September 08, 2026 | 9.083B |
| September 04, 2026 | 9.064B |
| September 03, 2026 | 9.157B |
| September 02, 2026 | 9.223B |
| September 01, 2026 | 9.109B |
| August 31, 2026 | 9.022B |
| August 28, 2026 | 8.867B |
| August 27, 2026 | 9.512B |
| August 26, 2026 | 9.777B |
| August 25, 2026 | 9.516B |
| August 24, 2026 | 9.517B |
| August 21, 2026 | 9.738B |
| August 20, 2026 | 9.420B |
| August 19, 2026 | 10.02B |
| August 18, 2026 | 9.567B |
| August 17, 2026 | 9.750B |
| August 14, 2026 | 9.483B |
| August 13, 2026 | 9.529B |
| August 12, 2026 | 10.03B |
| August 11, 2026 | 9.591B |
| August 10, 2026 | 9.487B |
| August 07, 2026 | 9.314B |
| Date | Value |
|---|---|
| August 06, 2026 | 9.576B |
| August 05, 2026 | 8.154B |
| August 04, 2026 | 7.899B |
| August 03, 2026 | 7.771B |
| July 31, 2026 | 7.836B |
| July 30, 2026 | 7.834B |
| July 29, 2026 | 7.367B |
| July 28, 2026 | 7.501B |
| July 27, 2026 | 8.059B |
| July 24, 2026 | 8.324B |
| July 23, 2026 | 8.243B |
| July 22, 2026 | 7.955B |
| July 21, 2026 | 8.116B |
| July 20, 2026 | 7.741B |
| July 17, 2026 | 8.020B |
| July 16, 2026 | 7.846B |
| July 15, 2026 | 8.132B |
| July 14, 2026 | 8.390B |
| July 13, 2026 | 8.024B |
| July 10, 2026 | 8.315B |
| July 09, 2026 | 8.542B |
| July 08, 2026 | 8.538B |
| July 07, 2026 | 8.286B |
| July 06, 2026 | 7.994B |
| July 02, 2026 | 8.135B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Insmed, Inc. | 27.83B |
| Perspective Therapeutics, Inc. | 87.67M |
| Vertex Pharmaceuticals, Inc. | 124.70B |
| AbbVie, Inc. | 518.65B |
| TG Therapeutics, Inc. | 8.452B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -83.72M |
| Total Expenses (Quarterly) | 83.72M |
| EPS Diluted (Quarterly) | -2.874 |
| Earnings Yield | -3.87% |
| Normalized Earnings Yield | -3.868 |